论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
中国医疗保险改革的持续性与变革:以解决 2019 冠状病毒疾病患者医疗费用的财政补贴政策为线索
Received 26 November 2021
Accepted for publication 11 May 2022
Published 24 May 2022 Volume 2022:15 Pages 1129—1144
DOI https://doi.org/10.2147/RMHP.S349124
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Kent Rondeau
Background: The system studied in this article is set in the development and reform of China’s healthcare insurance, the time mentioned in this article is during the COVID-19 period and the issues are about healthcare insurance fiscal subsidy policies for COVID-19 patients’ medical costs.
Methods: Method of comparison and method of case study are used. This article compares the healthcare insurance systems, fiscal subsidy policies during the COVID-19 period and takes Yulin’s healthcare insurance reform and Nanjing healthcare insurance administration’s measures to fight against COVID-19 pandemic as specific cases to analyze.
Aim: This article presents the advantages of the coverage of China’s healthcare insurance as well as the insufficiency of the commercial healthcare insurance and market-oriented medical institutions to show the persistence and change in China’s healthcare insurance reform.
Conclusion: Soon after the outbreak of COVID-19 pandemic, the National Healthcare Security Administration and the Ministry of Finance of PRC jointly issued an announcement on how to guarantee the medical security of the novel coronavirus pneumonia pandemic. More specific policies were made by each province to secure that the total medical costs of the COVID-19 confirmed and suspected patients were almost borne by healthcare insurance and government finance subsidy. These policies reveal two basic points ahead China’s healthcare reform: one is that China shall persist in positively promoting the universal healthcare insurance coverage program, which will break down barriers between urban and rural areas; the other is that the commercial medical insurance shall be a supplementary to social healthcare insurance and the market-oriented medical institutions shall be encouraged. The two basic points stand for the persistence and change in China’s healthcare reform. China’s healthcare insurance reform should accord with the requirement in specific age and stage.
Keywords: healthcare insurance, COVID-19 pandemic, medical costs, public health, disease prevention